What It Takes To Secure Funding in a More Selective Life Sciences Market

The pace of funding in life sciences has shifted in ways that can make it more difficult to navigate. Capital continues to move, but with greater attention to how companies operate and how decisions are supported. Investors are spending more time in diligence, asking more detailed questions, and expecting answers that are immediately accessible.

For leadership teams, this has notably changed what it means to be ready. Preparation is no longer limited to assembling financial information or refining a presentation. It extends into how the organization is structured, how plans are developed, and how quickly the team can respond when scrutiny deepens. In many cases, the outcome is shaped less by the opportunity itself and more by how effectively a company can demonstrate that it is prepared to carry it forward. Organizations that navigate diligence most successfully are often those that have anticipated questions, identified potential gaps, and addressed potential blind spots before investors uncover them.

Readiness Built In Advance

In the current funding environment, diligence moves quickly and requires depth. Investors are asking more detailed questions and expect answers that are supported and readily available. The pace of the process leaves little room to pause and assemble information. What is not already organized often becomes difficult to present under pressure. Even seemingly minor gaps such as inconsistent reporting, unclear ownership of key metrics, unsupported assumptions, or undocumented processes can quickly become areas of concern during diligence. Companies that invest in readiness well in advance of entering the market are often better positioned to respond with confidence, maintain credibility throughout the process, and avoid surprises that can delay transactions or impact valuation.

Preparation begins with financial readiness. Investors expect timely, GAAP-based financial statements supported by well-defined accounting and finance policies, strong internal processes, and a demonstrated commitment to compliance. Maintaining financial statements on a regular basis in accordance with GAAP can also help companies avoid time-consuming reconciliations when diligence begins. Investors frequently request monthly, quarterly, and annual financial information, and leadership teams are often expected to provide those materials quickly. When financial statements have been prepared consistently over time, companies are typically better positioned to respond efficiently and maintain momentum throughout the diligence process.

This foundation allows leadership teams to confidently articulate the company’s performance, growth strategy, capital needs, and operating model. It also supports reliable budgeting and forecasting, providing investors with greater confidence that management understands how capital will be deployed, how long it is expected to last, and what milestones it is intended to achieve. A forward-looking 24-month forecast often serves as a key tool for connecting strategic priorities, resource allocation, and anticipated growth to the broader funding narrative.

Beyond the numbers, investors evaluate whether the organization has the infrastructure and discipline to scale effectively. AAFCPAs advises clients to organize financial and operational information well in advance of diligence, enabling leadership to respond to investor inquiries efficiently and consistently. This includes ensuring compliance across critical areas such as tax filings, R&D credit documentation, payroll processes, financial controls, and regulatory requirements. Weaknesses in these areas can create unnecessary diligence concerns, while a proactive approach demonstrates operational maturity, reduces potential blind spots, and reinforces investor confidence in the organization’s ability to execute its long-term strategy. When financial reporting, budgeting, and forecasting are aligned, companies are better positioned to demonstrate operational discipline and provide investors with confidence in both historical performance and future projections.

Diligence also extends into areas that can create compliance or financial risk if not properly maintained. Investors will often review whether R&D credits are appropriately documented, state and local tax filings are current, and payroll-related compliance requirements have been met. These areas tend to surface naturally during diligence because they provide insight into the organization’s overall financial discipline and risk management practices. In many cases, unresolved issues can raise questions that extend beyond the financial statements, making proactive preparation important to maintaining credibility and avoiding surprises during the fundraising process.

Responsiveness plays a central role throughout. When leadership teams can answer questions with clarity and consistency, it allows the discussion to remain focused on the opportunity and the path forward. That continuity is difficult to maintain without a foundation that has been developed in advance.

For earlier-stage companies, the expectation centers on coherence. Even with limited operating history, investors are looking for a clear understanding of the company’s financial position and how it plans to move forward with the capital it is seeking.

The Story Beyond The Science

That foundation supports a broader conversation that often begins to take shape during diligence. Questions move beyond financial position into how the organization will operate as it grows. The discussion turns to how capital will be deployed, how quickly the company can scale, and what needs to be in place to support that progress.

For life sciences companies, this often centers on the connection between scientific advancement and operational execution. Investors are looking to understand how planned activities will translate into day-to-day requirements. Hiring plans, lab capacity, systems, and internal processes all become part of the discussion because they determine whether the organization can carry its work forward at the pace the science requires.

These elements are evaluated together. A decision to accelerate a program may require additional personnel, expanded lab space, and more structured processes to manage the work. When these assumptions are aligned, the path forward is easier to follow. When they are not, gaps tend to surface quickly. Hiring plans may not reflect the timing of key milestones. Infrastructure needs may not be fully incorporated into capital requirements. Forecasts may not account for how quickly costs scale as activity increases. These disconnects can slow discussions as investors work to reconcile how the business will operate in practice.

For life sciences organizations, this alignment is closely tied to how scientific progress will be supported over time. A clear connection between capital, operations, and execution helps demonstrate that the company is prepared to carry its work forward as demands increase.

Putting This Into Practice: Life Science Leadership

AAFCPAs works with life sciences companies to bring financial, operational, and strategic planning into alignment as they prepare for funding and growth. Our outsourced accounting and fractional CFO teams help structure financial information, develop forward-looking models, and connect those insights to hiring, infrastructure, and key business decisions. This allows leadership teams to respond to investor questions with clarity, supported by information that reflects how the organization is actually operating. As companies move through funding rounds and into their next stage of growth, we continue to support evolving needs across accounting, tax, and advisory—helping ensure that the foundation built during preparation can carry forward as complexity increases.

These insights were contributed by Destiny J. Flood, CPA, Partner, Commercial Outsourced Accounting & Fractional CFO and Ashleigh Hall, CPA, Consulting CFO.

Questions? Reach out to our authors directly or your AAFCPAs partner.

AAFCPAs offers a wealth of resources on life sciences strategy. Subscribe to get alerts and insights in your inbox.